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THE IMPACT OF HEALTH CARE FINANCING ON THE ECONOMIC GROWTH: 
EU COUNTRIES ANALYSIS 
 
Abstract. This article generalized modern tendencies and actual peculiarities of health care financing. The key 
aim of the research is to investigate the dynamics of health care financing as a factor of economic growth based on 
EU countries analysis. Systematization information sources connected with health care financing and its structure 
indicate that the EU countries analysis of dynamics of health care financing and its impact on economic growth was 
conducted fragmentary. This issue is still actual both for scholars and policymakers, especially for Ukraine, based on 
European trends. Investigation in the article is made according to the following stages: 1) introduction and relevance 
grounding; 2) literary review and identifying the necessity of research in this scientific area; 3) describing methodology, 
research methods, and current hypothesis; 4) characteristic of research results and confirming the hypothesis of the 
positive impact of the health care financing on economic growth; 5) making conclusions. Methodological tools of the 
research methods were structural and comparative analysis, logical generalization, and scientific abstraction. The 
methods of cross-country statistical and analytical analysis using the Excel 2010 software package for the sample 
from 14 EU countries for 2009-2018 (limited number of countries and limited data in 2018 relate to the data availability 
on open website of the EU statistical office) were applied to analyse the structure of health care financing, in particular 
financing schemes, main providers, and health care functions. The top countries in health care financing were 
identified. The methods of empirical analysis using the STATA software package for this data sample were used to 
confirm the hypothesis about the positive impact of the health care financing on economic growth – the GDP per 
capita. The nature of the analysed indices distribution was estimated based on results of Shapiro-Wilk test. So, 
Pearson or Spearman correlation coefficient was chosen. The statistical significance and strength of the relationship 
between the indicators of total expenditure for health care, and in particular government financing and compulsory 
contributory health care financing, voluntary health care financing, and household out-of-pocket payment for health 
care and the change of GDP per capita were assessed through a correlation analysis. The time lags of achievement 
the most statistical significance by this relationship was also identified. The results of the research show that the 
impact of health care financing on the change of economic growth is very high in 12 from 14 investigated EU countries 
(with lags of 1–3 years) and high in 2 from 14 countries (with a lag of 1 year). The character of this relationship for the 
most countries (9 from 14 countries) is direct (positive), and for 5 countries it is inverse (negative). The results of the 
research will be useful during future fundamental and practical research connected with health care financing and its 
modelling, for scholars and government officials to reform the health care system and its financial mechanism. 
Keywords: economic growth, expenditure for health care, GDP per capita, government health care financing, 
health care, health insurance, household health payment, provider of health care, voluntary health care financing. 
 
 
Introduction. With the rapid spread of the coronavirus pandemic and its negative consequences, 
doctors, scientists, and government officials have faced new challenges and targets. One of the priorities 
is to reform the state policy in the field of health care. Health care financing is an essential part of this 
policy, it is critical for reaching health coverage. 
The World Health Organization advises countries to develop responsive and resilient health systems 
that are centred on people’s needs and circumstances, backed by adequate funding, strong health plans 
and evidence-based policies (WHO, Health systems financing). In this context, the EU experience is useful 
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for many developing countries, especially for Ukraine. Despite much research in this scientific sphere, the 
impact of health care financing on the change of GDP per capita is covered fragmentary and needed the 
empirical confirmation. 
Thus, the paper aims to investigate the dynamics of health care financing as a driver of economic 
growth based on EU countries' analysis. 
Literature Review. Many scholars have studied the problem of health care and its different aspects. 
The appropriate role of the state in health was proved by Musgrove (1996). White (2001) characterized 
the future form of health care financing, being sure that modern e-health projects and the contribution 
approach could improve a financing system that rewards doctors who offer quality service and care. 
Schieber et al. (2006) assessed health financing policy in low- and middle-income countries, discussed 
the essential functions of health financing systems and the various mechanisms for effective revenue 
collection, pooling of resources, and purchasing interventions.  
Alkaravani (2014) identified the characteristics of the quality level of medical services and their 
marketing. Fan and Savedoff (2014) paid attention on health financing transition to provide a conceptual 
framework for understanding health markets and public policy. Bagmet and Obeid (2017) analysed the 
financial providing of social protection comparing Ukraine and the EU countries. Cylus et al. (2018) 
emphasized that health system is an essential macroeconomic link, a provider of many jobs, and a driver 
of a labor force. 
Antosova et al. (2019) showed healthcare availability in households with different income levels, 
studied public healthcare expenditure and R&D expenditure in this sphere. Stepovic (2019) analysed GDP 
growth and health care expenditures worldwide and proposed to make government investments in health 
as large as countries can afford due to the population aging, non-communicable disease and treatment, 
and pharmacological innovations. Yelnikova and Kwilinski (2020) investigated the implementation of 
impact-investing in the health care system and its comparison with other traditional investment 
mechanisms considering the socially responsible public investment policy. 
Systematization of these and other literary sources to describe the problem of health care financing 
indicates that the EU countries' analysis of dynamics of health care financing and its impact on economic 
growth was conducted fragmentary. This issue is still actual both for scholars and policymakers, especially 
for Ukraine, based on European trends. 
Methodology and research methods. Methodological tools of the research methods include 
structural and comparative analysis, logical generalization, scientific abstraction. Cross-country statistical 
and analytical analysis based on the Excel 2010 in 14 EU countries for 2009-2018 (limited number of 
countries and limited data in 2018 relate to the data available on open website of the EU statistical office) 
were applied to analyze the structure of health care financing, in particular financing schemes, main 
providers, health care functions.  
The correlation analysis based on the STATA software for these EU countries was applied to confirm 
the hypothesis on the positive impact of the health care financing on economic growth – the change of 
GDP per capita. The nature of the analysed indices distribution was estimated based on results of Shapiro-
Wilk test (Shapiro and Wilk, 1965). Then Pearson (for normal distribution) or Spearman (in case of 
absence of normal distribution) correlation coefficient was chosen (Pearson, 1896; Spearman, 1904). The 
statistical significance and strength of the relationship between the indicators of total expenditure for health 
care, and in particular government financing and compulsory contributory health care financing, voluntary 
health care financing, and household out-of-pocket payment for health care and the change of GDP per 
capita were assessed through a correlation analysis. The time lags of achievement the most statistical 
significance by this relationship was also identified. 
Results. Health care financing includes direct payments by households and third-party financing 
through which citizens obtain health services (Eurostat, 2020). The main ones are the following: 
1) government financing, compulsory contributory health insurance, social health insurance and 
compulsory private insurance schemes; 2) voluntary health insurance, non-profit institutions financing and 
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enterprise financing schemes; 3) household out-of-pocket payment; 4) resident abroad financing and other 
financing schemes. 
Health care financing covers the following health care functions: rehabilitative care, curative care, 
inpatient care, outpatient care, daycare, long-term care (health), home-based care, ancillary services, 
therapeutic appliances, pharmaceuticals, medical goods, preventive care, and governance. Accordingly, 
leading health care providers are residential long-term care facilities, hospitals, providers of ancillary 
services, providers of ambulatory healthcare, providers of medical goods and preventive care, healthcare 
administration etc (Eurostat, 2020). 
To investigate health care financing and expenditure structure the authors made the sample from 
14 EU countries for 2009-2018 (limited number of countries and limited data in 2018 relate to the data 
available on the website of the EU statistical office). Total expenditure for health care in these countries is 
presented in Table 1. 
 
Table 1. Total expenditure for health care, % of GDP 
Country 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 
Austria 10,23 10,22 10,03 10,20 10,29 10,37 10,37 10,36 10,36 10,32 
Belgium 10,36 10,23 10,39 10,51 10,56 10,44 10,43 10,28 10,41 10,32 
Cyprus 6,52 6,52 6,45 6,55 6,95 6,96 6,93 6,83 6,74 6,77 
Denmark 10,33 10,33 10,15 10,24 10,17 10,17 10,23 10,14 10,12 10,10 
Estonia 6,51 6,27 5,77 5,79 5,98 6,08 6,35 6,50 6,61 6,66 
Finland 9,16 9,14 9,22 9,59 9,81 9,78 9,65 9,38 9,14 9,04 
France 11,30 11,24 11,20 11,31 11,44 11,58 11,47 11,50 11,39 11,26 
Germany  11,24 11,10 10,78 10,85 10,99 11,02 11,16 11,23 11,37 11,47 
Greece 9,41 9,52 9,03 8,79 8,32 7,85 8,02 8,21 7,97 7,72 
Hungary 7,25 7,52 7,54 7,47 7,26 7,09 6,97 7,05 6,79 6,70 
Lithuania 7,36 6,83 6,51 6,29 6,14 6,20 6,49 6,64 6,47 6,57 
Netherlands 9,99 10,16 10,23 10,54 10,58 10,57 10,32 10,25 10,06 9,97 
Portugal 9,88 9,84 9,53 9,35 9,08 9,02 8,98 9,42 9,33 9,45 
Spain 9,11 9,12 9,17 9,16 9,07 9,09 9,13 8,95 8,94 8,99 
Source: developed by the author based on (Eurostat Data, Expenditure for selected health care 
providers by health care financing schemes, 2009–2018). 
 
The top countries in health care financing are Germany, France, Austria, Belgium, and Denmark (the 
share of the expenditure is more than 10% of GDP). The main elements of healthcare expenditure include 
government financing and compulsory contributory health care financing, voluntary health care financing, 
household out-of-pocket payment for health care, and others. Let us analyze these three expenditure 
components. 
Government financing and compulsory contributions are shown in Table 2. 
 
Table 2. Government financing and compulsory contributions, % of GDP 
Country 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 
Austria 7,68 7,63 7,48 7,62 7,61 7,67 7,68 7,66 7,66 7,71 
Belgium 7,88 7,79 7,90 8,03 8,03 7,92 7,90 7,82 7,90 7,82 
Cyprus 3,01 3,01 3,09 3,04 3,20 3,00 2,88 2,81 2,79 2,91 
Denmark 8,67 8,67 8,49 8,60 8,57 8,56 8,61 8,53 8,50 8,48 
Estonia 5,07 4,79 4,42 4,44 4,52 4,60 4,80 4,92 4,87 4,91 
Finland 7,10 7,05 7,16 7,49 7,64 7,63 7,42 7,15 6,99 6,95 
France 8,65 8,58 8,52 8,61 8,72 8,86 8,79 9,55 9,48 9,42 
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Continued Table 2 
Greece 6,43 6,56 5,93 5,81 5,13 4,53 4,62 4,99 4,82 4,53 
Hungary 4,95 5,05 5,02 4,89 4,84 4,76 4,75 4,80 4,70 4,65 
Lithuania 5,33 4,90 4,62 4,24 4,06 4,19 4,36 4,42 4,28 4,40 
Netherlands 8,31 8,47 8,46 8,65 8,59 8,57 8,40 8,32 8,21 8,19 
Portugal 6,91 6,86 6,45 6,13 6,07 5,96 5,94 5,79 5,70 5,81 
Spain 6,84 6,79 6,74 6,60 6,44 6,39 6,51 6,41 6,32 6,33 
Source: developed by the author based on (Eurostat Data, Expenditure for selected health care 
providers by health care financing schemes, 2009–2018). 
 
The highest level of government financing is in Germany, France, and Denmark. The comparison of 
voluntary health care financing is presented in Table 3. 
 
Table 3. Voluntary health care financing, % of GDP 
Country 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 
Austria 0,70 0,69 0,67 0,68 0,70 0,71 0,71 0,70 0,71 0,72 
Belgium 0,41 0,41 0,43 0,43 0,45 0,46 0,49 0,51 0,52 0,53 
Cyprus 0,68 0,68 0,67 0,72 0,75 0,80 0,90 0,87 0,88 0,84 
Denmark 0,18 0,18 0,19 0,19 0,20 0,21 0,22 0,22 0,23 0,24 
Estonia 0,12 0,11 0,10 0,10 0,11 0,10 0,10 0,11 0,11 0,12 
Finland 0,38 0,38 0,39 0,42 0,42 0,43 0,43 0,42 0,41 0,42 
France 1,50 1,52 1,54 1,56 1,58 1,58 1,57 0,85 0,82 0,80 
Germany 0,33 0,33 0,33 0,33 0,33 0,32 0,32 0,32 0,32 0,34 
Greece 0,20 0,27 0,27 0,29 0,28 0,31 0,32 0,34 0,34 0,36 
Hungary 0,39 0,41 0,40 0,38 0,36 0,32 0,30 0,30 0,26 0,24 
Lithuania 0,05 0,04 0,05 0,05 0,05 0,06 0,06 0,07 0,08 0,08 
Netherlands 0,77 0,76 0,80 0,82 0,77 0,77 0,76 0,78 0,73 0,71 
Portugal 0,54 0,56 0,57 0,59 0,55 0,56 0,55 0,84 0,84 0,84 
Spain 0,54 0,48 0,56 0,56 0,56 0,60 0,58 0,58 0,65 0,67 
Source: developed by the author based on (Eurostat Data, Expenditure for selected health care 
providers by health care financing schemes, 2009–2018). 
 
The share of voluntary health care financing is significantly less than governmental. The highest level 
is in Portugal, Cyprus, and France – about 0,8%. And household out-of-pocket payment for health care 
are shown in Table 4. 
 
Table 4. Household out-of-pocket payment for health care, % of GDP 
Country 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 
Austria 1,85 1,90 1,88 1,90 1,97 1,98 1,98 1,99 1,98 1,89 
Belgium 2,06 2,04 2,06 2,05 2,09 2,06 2,03 1,95 1,98 1,97 
Cyprus 2,81 2,81 2,67 2,78 2,96 3,14 3,10 3,15 3,07 3,02 
Denmark 1,49 1,49 1,48 1,45 1,40 1,40 1,40 1,39 1,39 1,39 
Estonia 1,32 1,38 1,24 1,25 1,35 1,38 1,45 1,47 1,64 1,64 
Finland 1,68 1,72 1,67 1,67 1,74 1,73 1,80 1,81 1,74 1,67 
France 1,15 1,15 1,15 1,14 1,14 1,14 1,11 1,10 1,09 1,04 
Germany  1,54 1,53 1,49 1,52 1,45 1,42 1,45 1,45 1,44 1,43 
Greece 2,78 2,69 2,81 2,68 2,83 2,91 2,95 2,87 2,79 2,81 
Hungary 1,90 2,06 2,13 2,19 2,06 2,01 1,91 1,95 1,83 1,80 
Lithuania 1,97 1,89 1,84 2,00 2,01 1,95 2,07 2,14 2,11 2,08 
Netherlands 0,91 0,92 0,97 1,06 1,22 1,22 1,17 1,16 1,11 1,08 
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Continued Table 4 
Portugal 2,43 2,42 2,51 2,64 2,45 2,50 2,49 2,79 2,79 2,79 
Spain 1,73 1,85 1,87 2,00 2,06 2,10 2,03 1,97 1,98 1,99 
Source: developed by the author based on (Eurostat Data, Expenditure for selected health care 
providers by health care financing schemes, 2009–2018). 
 
To investigate the dynamics of health care financing as a factor of economic growth we also need to 
generalise and analyse GDP data (Table 5). 
 
Table 5. GDP at market prices, percentage change on previous period, per capita, % 
Country 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 
Austria -4,00 1,60 2,60 0,20 -0,60 -0,10 0,00 0,70 1,80 2,10 
Belgium -2,80 1,90 0,40 0,10 0,00 1,10 1,50 0,80 1,20 1,30 
Cyprus -4,60 -0,60 -2,10 -4,90 -6,30 -0,70 3,80 6,00 4,20 4,00 
Denmark -5,40 1,40 0,90 -0,10 0,50 1,10 1,60 2,40 2,20 1,70 
Estonia -14,30 2,90 7,70 3,50 1,70 3,30 2,00 3,00 5,50 4,10 
Finland -8,50 2,70 2,10 -1,90 -1,40 -0,80 0,20 2,50 3,00 1,20 
France -3,40 1,40 1,70 -0,20 0,10 0,50 0,70 0,70 1,90 1,50 
Germany -5,40 4,40 3,90 0,20 0,20 1,80 0,60 1,40 2,20 1,00 
Greece -4,60 -5,60 -10,00 -6,60 -2,00 1,40 0,20 -0,10 1,50 1,80 
Hungary -6,60 1,40 2,20 -0,90 2,10 4,50 4,10 2,40 4,60 5,50 
Lithuania -13,90 3,80 8,50 5,20 4,60 4,40 3,00 3,80 5,80 4,90 
Netherlands -4,20 0,80 1,10 -1,40 -0,40 1,10 1,50 1,70 2,30 1,80 
Portugal -3,20 1,70 -1,60 -3,70 -0,40 1,30 2,20 2,30 3,80 3,00 
Spain -4,60 -0,30 -1,20 -3,00 -1,10 1,70 3,90 2,90 2,80 2,00 
Source: developed by the author based on (Eurostat Data, Main GDP aggregates per capita, 2009–
2018). 
 
To confirm or refute the hypothesis about the impact of dynamics of health care financing on economic 
growth we calculated the corresponding correlation coefficients. Previously we checked whether the 
indicators of total expenditure for health care (TE), and in particular government financing and compulsory 
contributory health care financing (GF), voluntary health care financing (VF), and household out-of-pocket 
payment for health care (HP) obey the law of normal distribution based on the results of Shapiro–Wilk test 
(Table 6). Calculations were made in the STATA software. 
 
Table 6. The results of the Shapiro–Wilk test regarding the subordination of indices of health 
care financing to the normal distribution 
 W V z Prob>z  W V z Prob>z 
Austria Belgium 
TE 0.80741 2.968 2.101 0.01783* TE 0.98744 0.193 -2.438 0.99262 
GF 0.83366 2.563 1.786 0.03703* GF 0.94095 0.910 -0.160 0.56363 
VF 0.92697 1.125 0.205 0.41879 VF 0.90341 1.489 0.710 0.23871 
HP 0.84484 2.391 1.641 0.05042 HP 0.87295 1.958 1.236 0.10820 
Cyprus Denmark 
TE 0.89510 1.617 0.865 0.19340 TE 0.93249 1.040 0.068 0.47286 
GF 0.96396 0.555 -0.954 0.82988 GF 0.97767 0.344 -1.660 0.95150 
VF 0.90401 1.479 0.699 0.24230 VF 0.93407 1.016 0.027 0.48908 
HP 0.91157 1.363 0.548 0.29196 HP 0.84006 2.465 1.704 0.04420* 
Estonia Finland 
TE 0.91665 1.284 0.440 0.32990 TE 0.88565 1.762 1.030 0.15139 
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Continued Table 6 
GF 0.92637 1.135 0.220 0.41311 GF 0.88341 1.797 1.068 0.14277 
VF 0.97213 0.430 -1.340 0.90983 VF 0.91010 1.385 0.578 0.28168 
HP 0.95179 0.743 -0.495 0.68974 HP 0.87668 1.900 1.177 0.11951 
France Germany 
TE 0.95401 0.709 -0.571 0.71602 TE 0.98118 0.290 -1.899 0.97119 
GF 0.80951 2.936 2.077 0.01891* GF 0.96887 0.480 -1.176 0.88016 
VF 0.70799 4.500 3.062 0.00110* VF 0.84661 2.364  1.617 0.05293 
HP 0.78597 3.298 2.334 0.00979* HP 0.88296 1.804  1.075 0.14111 
Greece Hungary 
TE 0.90100 1.526  0.756 0.22470 TE 0.93978 0.928 -0.127 0.55052 
GF 0.87224 1.969  1.247 0.10616 GF 0.95879 0.635 -0.745 0.77198 
VF 0.95243 0.733 -0.517 0.69727 VF 0.92851 1.102  0.168 0.43340 
HP 0.95911 0.630 -0.758 0.77566 HP 0.97189 0.433 -1.327 0.90778 
Lithuania Netherlands 
TE 0.89018 1.692  0.953 0.17038 TE 0.90374 1.483  0.704 0.24070 
GF 0.86761 2.040  1.318 0.09375 GF 0.95107 0.754 -0.471 0.68122 
VF 0.93845 0.949 -0.090 0.53589 VF 0.97241 0.425 -1.355 0.91224 
HP 0.96904 0.477 -1.184 0.88176 HP 0.96815 0.491 -1.141 0.87315 
Portugal Spain 
TE 0.92808 1.108 0.178 0.42925 TE 0.88761 1.732  0.997 0.15936 
GF 0.86031 2.153 1.426 0.07696 GF 0.89548 1.611  0.858 0.19531 
VF 0.77392 3.484 2.458 0.00698* VF 0.96177 0.589 -0.863 0.80587 
HP 0.92628 1.136 0.222 0.41234 HP 0.92468 1.161  0.259 0.39766 
* – outside the normal distribution 
Source: developed by the author using STATA software package. 
 
Then we calculated the Pearson correlation coefficient (the normal distribution, the result of Shapiro–
Wilk test > 0,05) or Spearman correlation coefficient (indices are outside the normal distribution, the result 
of Shapiro–Wilk test < 0,05) to define the statistical significance and strength of the relationship between 
investigated indices. Also, we determined the correlation coefficients considering the time lags to increase 
the adequacy of investigated indices.  
Table 7 shows the summarized results of the impact of the dynamics of health care financing (in 
general and by different schemes) on the change of economic growth (GDP per capita). 
 
Table 7. The statistical significance and strength of the impact of the dynamics of health care 
financing and the change of GDP per capita 
Country 
TE GF VF HP 







Austria 0.8469 2 0.8571 2 0.7779 3 0.8033 3 
Belgium 0.6904 3 0.6372 3 0.6872 2 -0.3882 0 
Cyprus 0.9500 2 -0.9063 1 0.8682 1 0.9214 1 
Denmark -0.7914 3 -0.5772 0 0.8473 2 -0.9258 0 
Estonia 0.7767 2 0.8569 2 0.5642 2 0.3841 3 
Finland 0.9589 3 0.9462 3 0.8936 3 0.6056 1 
France 0.8369 3 0.9910 1 0.9000 3 -0.9162 1 
Germany 0.5021 1 0.3945 2 -0.4750 3 0.5251 1 
Greece -0.9128 1 -0.8868 1 0.9225 3 0.5740 0 
Hungary -0.7290 1 -0.7688 1 -0.7449 1 -0.4886 1 
Lithuania 0.9287 2 0.8739 2 0.4119 3  -0.2171* 1 
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Continued Table 7 
Netherlands 0.8820 3 0.6738 3 -0.7054 1 0.8674 3 
Portugal -0.8958 3 -0.9479 2 0.6736 0 0.4749 0 
Spain -0.5817 1 -0.9070 2 0.8001 2 0.8762 3 
* the effect is statistically insignificant in case of acceptable calculations (time lag from 0 to 3 years) 
Source: developed by the author using STATA software package. 
 
In this research we supposed the impact is not significant in case of a weak relationship (a correlation 
coefficient < 0,3). Average influence is in case of a correlation coefficient from 0,3 to 0,5, high – from 0,5 
to 0,7, and very high – more than 0,7. 
Also, the correlation analysis of the relationship between the dynamics of total expenditure for health 
care and the change of economic growth in these countries grounded the duration of time lags of statistical 
significance of investigated indices: very high – in Greece and Hungary (with a lag of 1 year), in Austria, 
Cyprus, Estonia, and Lithuania (with a lag of 2 years), in Belgium, Denmark, Finland, Netherlands, 
Portugal and France (with a lag of 3 years) and high – in Germany and Spain (with a lag of 1 year). The 
impact character for 9 countries is direct, for 5 countries – inverse. 
In particular, the correlation analysis of the impact of the dynamics of government financing and 
compulsory contributory health care financing, voluntary health care financing, household out-of-pocket 
payment for health care on the change of GDP per capita grounded the duration of time lags of statistical 
significance of investigated indices: 
− for government health care financing: very high – in France, Cyprus, Greece, and Hungary (with 
a lag of 1 year), in Austria, Estonia, Lithuania, Spain and Portugal (with a lag of 2 years), high – in Denmark 
(without a time lag), in Belgium, Finland and Netherlands (with a lag of 3 years), average – in Germany 
(with a lag of 2 years). The impact character for 8 countries is direct, for 6 countries – inverse; 
− for voluntary health care financing: very high – in Hungary, Cyprus, and Netherlands (with a lag of 
1 year), in Denmark and Spain (with a lag of 2 years), in Austria, Finland, Greece, and France (with a lag 
of 3 years), high – in Portugal (without a time lag), in Belgium and Estonia (with a lag of 2 years), average 
– in Germany and Lithuania (with a lag of 3 years). The impact character for 11 countries is direct, for 3 
countries – inverse; 
− for household out-of-pocket payment for health care: very high – in Denmark (without a time lag), 
in France and Cyprus (with a lag of 1 year), in Austria, Netherlands, and Spain (with a lag of 3 years), high 
– in Greece (without a time lag), in Finland and Germany (with a lag of 1 year), average – in Belgium and 
Portugal (without a time lag), in Hungary (with a lag of 1 year), in Estonia (with a lag of 3 years). The 
impact character for 9 countries is direct, for 5 countries – inverse. 
Therefore, we prove the hypothesis about the positive impact of health care financing on the economic 
growth. 
Conclusions. In this research we analysed the structure of health care financing, in particular 
financing schemes, main providers, and health care functions for the sample from 14 EU countries for 
2009-2018. The top countries in health care financing were identified. They are Germany, France, Austria, 
Belgium, and Denmark (the share of the expenditure is more than 10% of GDP). Using the STATA 
software package, the nature of the investigated indices distribution was estimated based on Shapiro-Wilk 
test, the results of which made it possible to choose the method to calculate the correlation coefficient – 
Pearson or Spearman. The correlation analysis of the impact of the dynamics of total expenditure for 
health care on the change of GDP per capita confirmed the hypothesis that health care financing is an 
important factor of economic growth. We determined the time lags, when this impact is statistically 
significant: very high – in 12 from 14 investigated EU countries (with a lag of 1–3 years) and high in 2 from 
14 countries (with a lag of 1 year). The character of this relationship for the most countries (9 from 14 
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countries) is direct (positive), and for 5 countries it is inverse (negative). Separately we showed the results 
of the correlation analysis of the relationship between the dynamics of government financing and 
compulsory contributory health care financing, voluntary health care financing, household out-of-pocket 
payment for health care and the change in GDP per capita. For the most countries the relationship is 
statistically significant with very high or high impact and positive effect. The time lags differ from 0 to 3 
years. So, we proved the hypothesis about the positive impact of health care financing on the economic 
growth in a country, and it will be deeper developed in future research. 
Author Contributions: conceptualization, A.S. and R.K.; methodology, A.S.; software, A.S.; 
validation, A.S. and R.K.; formal analysis, A.S.; investigation, A.S.; resources, A.S.; data curation, A.S.; 
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supervision, A.S.; project administration, A.S. 





Alkaravani, B. T. (2014). Marketing research of medical services quality. Marketing and management of innovations, 1, 124-
131. Retrieved from: [Link] 
Antosova, I., Hazuchova, N., & Stakova, J. (2019). Market Segmentation in Healthcare. Marketing and Management of 
Innovations, 3, 151-166. [Google Scholar] [CrossRef] 
Bagmet, K., & Obeid, H. (2017). Financing social protection in Ukraine and the European Union: current situation and prospects. 
SocioEconomic Challenges, 1 (1), 54-59. [Google Scholar] [CrossRef] 
Cylus J., Permanand, G., & Smith, P.C. (2018). Making the economic case for investing in health systems: What is the evidence 
that health systems advance economic and fiscal objectives? Policy brief. the WHO Regional Office for Europe, Denmark. [Google 
Scholar] 
Eurostat Data. Expenditure for selected health care providers by health care financing schemes. Retrieved from [Link] 
Eurostat Data. Main GDP aggregates per capita. Retrieved from [Link] 
Eurostat. (2020). Consolidated quality report on healthcare expenditure and financing statistics. Luxembourg: Publications 
Office of the European Union. [CrossRef] 
Fan, V. Y., & Savedoff, W. D. (2014). The health financing transition: a conceptual framework and empirical evidence. Social 
science & medicine, 105, 112-121. [Google Scholar] [CrossRef] 
Musgrove, P. Public and provate roles in health: theory and financing patterns. In Public and provate roles in health: theory and 
financing patterns (pp. 79-79). [Google Scholar] 
Pearson, K. (1896). Mathematical contributions to the theory of evolution—III. Regression, heredity, and panmixia. Philosophical 
Transactions of the Royal Society of London, Series A 187, 253–318.[Google Scholar] 
Schieber, G., Baeza, C., Kress, D., Maier, M., Jamison, D., Breman, J., & Measham, A. (2006). Health financing systems in the 
21st century. Disease Control Priorities in Developing Countries. 2nd edition (New York: Oxford University Press) pp, 225-242. 
[Google Scholar] [CrossRef] 
Shapiro, S., & Wilk, М. (1965). An analysis of variance test for normality (complete samples). Biometrika, 52, 591–611. [Google 
Scholar] 
Spearman, C. E. (1904). The proof and measurement of association between two things. American Journal of Psychology, 15, 
72–101.[Google Scholar] 
Stepovic, M. (2019). GDP Growth and Health Care Expenditures Worldwide. Wentham Open. 7, 9-18. 
https://doi.org/10.2174/1874129001907010009 
White, B. (2001). The Future of Health Care Financing. Fam Pract Manag, 8(1), 1-36. Retrieved from: 
https://www.aafp.org/fpm/2001/0100/p31.html 
WHO (n. d.). Health systems: key expected results. Retrieved from: https://www.who.int/healthsystems/about/progress-
challenges/en/ 
Yelnikova, J., & Kwilinski, A. (2020). Impact-Investing in The Healthcare in Terms of the New Socially Responsible State 
Investment Policy. Business Ethics and Leadership, 4(3), 57-64. https://doi.org/10.21272/bel.4(3).57-64.2020. 
 
 
А. В. Самойлікова, к.е.н., Сумський державний університет (Україна). 
P. Кунєв, директор, ТОВ «Vazhod-2019» (Болгарія) 
Вплив фінансування охорони здоров'я на економічне зростання: аналіз країн ЄС 
У цій роботі узагальнено сучасні тенденції та актуальні особливості фінансування охорони здоров’я. Основна мета 
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дослідження – дослідити динаміку фінансування охорони здоров’я як факторe економічного зростання на основі аналізу 
країн ЄС. Систематизація літературних джерел та підходів до вирішення проблеми фінансування охорони здоров’я та 
його структури свідчить про те, що аналіз динаміки фінансування охорони здоров’я та його впливу на економічне 
зростання в країнах ЄС проводився фрагментарно. Актуальність вирішення цієї наукової проблеми полягає в тому, що 
це питання досі є актуальним як для науковців, так і для політиків, особливо для України на основі європейського досвіду. 
Дослідження теми в роботі здійснюється в такій логічній послідовності: 1) вступ та обґрунтування актуальності; 
2) огляд літератури та виявлення необхідності дослідження у цій науковій галузі; 3) опис методології, методів 
дослідження та поточної гіпотези; 4) характеристика результатів дослідження та підтвердження гіпотези про 
позитивний вплив фінансування охорони здоров’я на економічне зростання; 5) надання висновків. Методологічними 
інструментами методів дослідження були структурний та порівняльний аналіз, логічне узагальнення та наукова 
абстракція. Методи міждержавного статистичного та аналітичного аналізу з використанням програмного пакету 
Excel 2010 для вибірки з 14 країн ЄС на 2009-2018 роки (обмежена кількість країн та обмежені дані 2018 роком через 
наявність інформації на відкритому інформаційному порталі статистичного офісу Європейського Союзу) були 
застосовані для аналізу структури фінансування охорони здоров’я, зокрема схем фінансування, основних постачальників 
та функцій охорони здоров’я. Були визначені топові країни у фінансуванні охорони здоров’я. Для підтвердження гіпотези 
про позитивний вплив фінансування охорони здоров’я на економічне зростання – динаміку ВВП на душу населення 
застосовувались методи емпіричного аналізу із використанням програмного пакету STATA для цієї вибірки країн ЄС. 
Характер розподілу досліджуваних показників оцінювали за допомогою критерію Шапіро–Вілка, за результатами якого 
було обрано розрахунковий метод коефіцієнта кореляції (Пірсона або Спірмена). Сила та характер взаємозв’язку між 
показниками загальних витрат на охорону здоров’я, зокрема державним фінансуванням, обов'язковими внесками на 
фінансування охорони здоров’я, добровільним фінансуванням охорони здоров'я, виплатою домогосподарствами коштів 
за охорону здоров'я та динамікою ВВП на душу населення були встановлені за допомогою кореляційного аналізу. Він 
виявив тривалість часових лагів, через які цей взаємозв’язок є найбільш статистично значущим. Результати 
дослідження показують, що вплив фінансування охорони здоров’я на економічне зростання країни є дуже високим у 12 із 
14 досліджуваних країн ЄС (із лагом 1–3 роки) та високим у 2 із 14 країн (із лагом 1 рік). Характер цих відносин для 
більшості країн (9 із 14 країн) є прямим (позитивним), а для 5 країн – зворотним (негативним). Результати дослідження 
будуть корисні під час майбутніх фундаментальних та практичних досліджень, пов’язаних з фінансуванням охорони 
здоров’я та його моделюванням, для науковців та державних службовців для реформування системи охорони здоров’я 
та її фінансового механізму. 
Ключові слова: ВВП на душу населення, витрати на охорону здоров’я, державне фінансування охорони здоров’я, 
добровільне фінансування охорони здоров’я, домогосподарства, економічне зростання, медичне страхування, охорона 
здоров’я, постачальник медичної допомоги. 
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